RenovoRx

RNXTNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$50.511 M

$1.12 -2.61%

Close of 7 Aug 2026

Revenue

$1.12M

#3493 by revenue

Earnings

-$11.2M

Loss-making

Shares outstanding

45,052,706

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#347Stablecoin DevelopmentSDEV$52.1M
#348ScynexisSCYX$52.0M
#349RenovoRxRNXT$50.5M
#350China PharmaCPHI$48.6M
#351Alaunos TherapeuticsTCRT$48.6M

Where these numbers come from

Share counts and financials for RenovoRx are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.